XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

202 hedge funds and large institutions have $2.95B invested in Xenon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 76 increasing their positions, 62 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
202
Holders Change
-11
Holders Change %
-5.16%
% of All Funds
2.92%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
13
Increased
76
Reduced
62
Closed
24
Calls
$4.78M
Puts
$1.13M
Net Calls
+$3.64M
Net Calls Change
-$3.37M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$101M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$38.5M
3
SC
3
Samlyn Capital
New York
$40.2M
4
VPC
4
Vestal Point Capital
New York
$32.5M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$82M

Top Sellers

1
PBA
1
Paradigm Biocapital Advisors
New York
$0
2
Invesco
2
Invesco
Georgia
$8.5M
3
AG
3
Artal Group
Luxembourg
$0
4
LGM
4
Logos Global Management
California
$0
5
BCM
5
Boone Capital Management
Georgia
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EC
226
EntryPoint Capital
New York
– -$1.01K -26 Closed
6 7 8 9
10